News
06-16-2010, 06:15 AM
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the breast cancer drug market in Brazil will grow from $424 million in 2009 to $611 million in 2014. Factors promoting the market's growth include steady increases in the number of incident breast cancer cases, shifts toward higher-cost chemotherapy and hormonal regimens in the adjuvant setting and increases in the use of targeted therapies following novel product launches and label extensions.
More... (http://www.news-medical.net/news/20100616/Brazilian-breast-cancer-drug-market-to-grow-from-24424M-in-2009-to-24611M-in-2014-Decision-Resources.aspx)
More... (http://www.news-medical.net/news/20100616/Brazilian-breast-cancer-drug-market-to-grow-from-24424M-in-2009-to-24611M-in-2014-Decision-Resources.aspx)